__PRESENT__PRESENT
__PRESENT__PRESENT__PRESENT
__PRESENT
__PRESENT
Enter your details to join our mobile app waitlist and receive early access to the Bell Direct App.
Latest stock market podcasts
Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst
Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.
In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action
Note: This interview was filmed on 7 February 2023.
Highest Overall
Client Satisfaction
2013-2023
Client Satisfaction
2013-2023
Best Rated Brand
Share Trading Platform
Overall 2021-2022